Literature DB >> 9462486

The immunobiology of interferon-gamma inducible protein 10 kD (IP-10): a novel, pleiotropic member of the C-X-C chemokine superfamily.

L F Neville1, G Mathiak, O Bagasra.   

Abstract

Interferon-gamma inducible protein 10 kD (IP-10) is a highly inducible, primary response gene that belongs to the C-X-C chemokine superfamily. Despite the original cloning of IP-10 in 1985, its biological functions are still unclear although accumulating reports indicate that it is a pleiotropic molecule capable of eliciting potent biological effects, including stimulation of monocytes, natural killer and T-cell migration, regulation of T-cell and bone marrow progenitor maturation, modulation of adhesion molecule expression as well as inhibition of angiogenesis. More interest is now likely to be focused on IP-10 due to the recent cloning of an IP-10 receptor. This paper aims to highlight our current knowledge of IP-10 and its homologues as well as defining its likely involvement in regulating fibroproliferation following inflammatory lung injury.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9462486     DOI: 10.1016/s1359-6101(97)00015-4

Source DB:  PubMed          Journal:  Cytokine Growth Factor Rev        ISSN: 1359-6101            Impact factor:   7.638


  111 in total

1.  Multiple CC chemokines in channel catfish and blue catfish as revealed by analysis of expressed sequence tags.

Authors:  Chongbo He; Eric Peatman; Puttharat Baoprasertkul; Huseyin Kucuktas; Zhanjiang Liu
Journal:  Immunogenetics       Date:  2004-08-07       Impact factor: 2.846

2.  Critical role for perforin and Fas-dependent killing of dendritic cells in the control of inflammation.

Authors:  Min Chen; Kumar Felix; Jin Wang
Journal:  Blood       Date:  2011-10-31       Impact factor: 22.113

Review 3.  Role of TWEAK in lupus nephritis: a bench-to-bedside review.

Authors:  Jennifer S Michaelson; Nicolas Wisniacki; Linda C Burkly; Chaim Putterman
Journal:  J Autoimmun       Date:  2012-06-22       Impact factor: 7.094

4.  Membrane array and multiplex bead analysis of tear cytokines in systemic sclerosis.

Authors:  Aniko Rentka; Jolan Harsfalvi; Gabriella Szucs; Zoltan Szekanecz; Peter Szodoray; Krisztina Koroskenyi; Adam Kemeny-Beke
Journal:  Immunol Res       Date:  2016-04       Impact factor: 2.829

5.  Pegylated interferon α-2b up-regulates specific CD8+ T cells in patients with chronic hepatitis B.

Authors:  Ji Chen; Yan Wang; Xue-Jie Wu; Jun Li; Feng-Qin Hou; Gui-Qiang Wang
Journal:  World J Gastroenterol       Date:  2010-12-28       Impact factor: 5.742

6.  Maternal serum concentrations of the chemokine CXCL10/IP-10 are elevated in acute pyelonephritis during pregnancy.

Authors:  Francesca Gotsch; Roberto Romero; Jimmy Espinoza; Juan Pedro Kusanovic; Shali Mazaki-Tovi; Offer Erez; Nandor Gabor Than; Samuel Edwin; Moshe Mazor; Bo Hyan Yoon; Sonia S Hassan
Journal:  J Matern Fetal Neonatal Med       Date:  2007-10

7.  Enhanced expression of interferon-inducible protein-10 correlates with disease activity and clinical manifestations in systemic lupus erythematosus.

Authors:  K O Kong; A W Tan; B Y H Thong; T Y Lian; Y K Cheng; C L Teh; E T Koh; H H Chng; W G Law; T C Lau; K P Leong; B P Leung; H S Howe
Journal:  Clin Exp Immunol       Date:  2009-01-23       Impact factor: 4.330

8.  Human adenovirus type 37 and the BALB/c mouse: progress toward a restricted adenovirus keratitis model (an American Ophthalmological Society thesis).

Authors:  James Chodosh
Journal:  Trans Am Ophthalmol Soc       Date:  2006

9.  The PA-gene-mediated lethal dissemination and excessive innate immune response contribute to the high virulence of H5N1 avian influenza virus in mice.

Authors:  Jiao Hu; Zenglei Hu; Qingqing Song; Min Gu; Xiaowen Liu; Xiaoquan Wang; Shunlin Hu; Chaoyang Chen; Huimou Liu; Wenbo Liu; Sujuan Chen; Daxin Peng; Xiufan Liu
Journal:  J Virol       Date:  2012-12-19       Impact factor: 5.103

10.  The emerging role of CXCL10 in cancer (Review).

Authors:  Mingli Liu; Shanchun Guo; Jonathan K Stiles
Journal:  Oncol Lett       Date:  2011-05-09       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.